Experience
Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc.
Classen Immunotherapies, Inc.
Elan Pharmaceuticals, Inc.
Defending Elan at district court and in two appeals with respect to Classen’s infringement allegations regarding Elan’s Skelaxin® portfolio. District court granted summary judgment of non-infringement in favor of Elan. Federal Circuit affirmed, and Supreme Court denied cert. Also successfully represented Elan in related reexamination proceedings before the U.S. Patent and Trademark Office (USPTO).
Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc., 1:04-cv-03521, D. Md., Judges Bennett, Quarles, Sullivan
Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc., 14-1671, Fed. Cir., Judges Prost, Lourie, Gilstrap
Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc., 17-1033, Fed. Cir., Judges Prost, Lourie, Taranto
